Aridis Pharmaceuticals, Inc. (ARDS)

OTCMKTS: ARDS · Delayed Price · USD
0.0750
-0.0029 (-3.72%)
Feb 23, 2024, 3:03 PM EST - Market closed

Aridis Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Cash & Equivalents
4.8819.998.2320.924.2425.122.29
Cash & Cash Equivalents
4.8819.998.2320.924.2425.122.29
Cash Growth
-75.60%142.78%-60.61%-13.78%-3.42%12.58%-
Receivables
1.240.240.370.411.6600.07
Inventory
0-0.24-0.37-0.41-4.1100
Other Current Assets
5.516.816.897.072.450.240.05
Total Current Assets
11.6326.815.1227.9724.2425.3422.41
Property, Plant & Equipment
2.151.361.261.011.270.750.04
Long-Term Investments
0000.010.9600
Intangible Assets
0.020.020.030.030.040.040.05
Other Long-Term Assets
0.910.930.990.565.110.350.04
Total Long-Term Assets
3.072.312.271.67.371.140.13
Total Assets
14.726.815.1227.9731.6126.4822.54
Accounts Payable
2.315.241.891.762.330.930.68
Deferred Revenue
20.1720.8418.7514.60.020.120
Current Debt
4.840.70.4402.4900
Other Current Liabilities
9.586.571.372.970.462.121.72
Total Current Liabilities
36.933.3522.4419.335.33.172.4
Long-Term Debt
1.295.280.280000
Other Long-Term Liabilities
0.741.281.085011.876.37
Total Long-Term Liabilities
2.036.561.365011.876.37
Total Liabilities
38.9340.9123.824.335.315.048.76
Total Debt
6.135.980.720000
Debt Growth
2.54%736.08%-----
Common Stock
0000000
Retained Earnings
-195.67-165.3-123.1-100.77-71.09-47.63-20.18
Comprehensive Income
5.05000-0.49-0.22-0.16
Shareholders' Equity
-24.23-14.11-8.683.6426.3111.4413.78
Total Liabilities and Equity
14.726.815.1227.9731.6126.4822.54
Net Cash / Debt
-1.2514.017.5220.924.2425.122.29
Net Cash / Debt Growth
-86.35%-64.03%-13.78%-3.42%12.58%-
Net Cash Per Share
-0.071.140.822.477.703.182.83
Working Capital
-25.27-6.55-7.328.6418.9422.1720.01
Book Value Per Share
-1.29-1.15-0.950.438.361.451.75
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.